Literature DB >> 20825491

Up-regulation of PSF1 promotes the growth of breast cancer cells.

Izumi Nakahara1, Mamiko Miyamoto, Tatsuhiro Shibata, Sadako Akashi-Tanaka, Takayuki Kinoshita, Kaoru Mogushi, Kohtaro Oda, Masaya Ueno, Nobuyuki Takakura, Hiroshi Mizushima, Hiroshi Tanaka, Tsutomu Ohta.   

Abstract

PSF1 is a subunit of the GINS complex that functions along with the MCM2-7 complex and Cdc45 in eukaryotic DNA replication. Although mammalian PSF1 is predominantly expressed in highly proliferating cells and organs, little is known about the roles of PSF1 in mature cells or cancer cells. We found that PSF1 was expressed at relatively high levels in breast tumor cells, but at low levels in normal breast cells. Knockdown of PSF1 expression using small interfering RNA (siRNA) slowed the growth of breast cancer cell lines by delaying DNA replication but did not affect proliferation of normal human mammary epithelial cells. Reduced PSF1 expression also inhibited anchorage-independent growth in breast cancer cell lines. These results suggest that PSF1 over-expression is specifically involved in breast cancer cell growth. Therefore, PSF1 inhibition might provide new therapeutic approaches for breast cancer.
© 2010 The Authors. Journal compilation © 2010 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825491     DOI: 10.1111/j.1365-2443.2010.01442.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  20 in total

1.  Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro.

Authors:  Jingyao Zhang; Qifei Wu; Zhe Wang; Yong Zhang; Guangjian Zhang; Junke Fu; Chang Liu
Journal:  Tumour Biol       Date:  2014-11-15

2.  Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.

Authors:  L Tang; W Yu; Y Wang; H Li; Z Shen
Journal:  Clin Transl Oncol       Date:  2019-04-08       Impact factor: 3.405

3.  Cytotoxicity and growth-inhibiting activity of Astragalus polysaccharides against breast cancer via the regulation of EGFR and ANXA1.

Authors:  Wenfang Li; Xueyan Hu; Yanjie Li; Kedong Song
Journal:  J Nat Med       Date:  2021-05-27       Impact factor: 2.343

4.  Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.

Authors:  Yun-Long Shen; He-Zhen Li; Yan-Wei Hu; Lei Zheng; Qian Wang
Journal:  CNS Neurosci Ther       Date:  2018-10-18       Impact factor: 5.243

5.  Expression and prognosis analysis of GINS subunits in human breast cancer.

Authors:  Hongtao Li; Yanzhen Cao; Jing Ma; Lin Luo; Binlin Ma
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

6.  DNA damage enhanced by the attenuation of SLD5 delays cell cycle restoration in normal cells but not in cancer cells.

Authors:  Zhi-Yuan Gong; Hiroyasu Kidoya; Tomomi Mohri; Yinglu Han; Nobuyuki Takakura
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

7.  Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer.

Authors:  Xiaoli Sun; Wu Sui; Miaoling Huang; Yeli Wang; Yuanjie Xuan; Zaiqiu Wang
Journal:  Diagn Pathol       Date:  2014-11-18       Impact factor: 2.644

8.  Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.

Authors:  Shafquat Azim; Haseeb Zubair; Sanjeev K Srivastava; Arun Bhardwaj; Asif Zubair; Aamir Ahmad; Seema Singh; Moh'd Khushman; Ajay P Singh
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

9.  Significant role of Psf3 expression in non-small-cell lung cancer.

Authors:  Shinya Tane; Yasuhiro Sakai; Daisuke Hokka; Hiromichi Okuma; Hiroyuki Ogawa; Yugo Tanaka; Kazuya Uchino; Wataru Nishio; Masahiro Yoshimura; Yoshimasa Maniwa
Journal:  Cancer Sci       Date:  2015-10-07       Impact factor: 6.716

10.  Effect of GINS2 on proliferation and apoptosis in leukemic cell line.

Authors:  Xi Zhang; Liang Zhong; Bei-Zhong Liu; Yan-Jun Gao; Yuan-Mei Gao; Xiu-Xiu Hu
Journal:  Int J Med Sci       Date:  2013-10-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.